Jim Mazzola | SVP, Communication and IR |
Athena Countouriotis | President and CEO |
Mohammad Hirmand | Chief Medical Officer |
Charles Zhu | Guggenheim Securities |
Paul Choi | Goldman Sachs |
Matt Biegler | Oppenheimer |
Zegbeh Jallah | ROTH Capital Partners |
Silvan Turkcan | JMP Securities |
Arlinda Lee | Canaccord |
Thank you all for standing by, and welcome to the Turning Point Therapeutics First Quarter 2021 Conference Call. All lines have been placed in listen-only mode until the question-and-answer session of today's conference. [Operator Instructions] I'll now hand the call over to your host, Jim Mazzola. Sir, you may begin.
Okay.